Abbott | ABT - Ebitda

Stock Price
114.58
Daily Change
-0.71 -0.62%
Monthly
5.34%
Yearly
-15.64%
Q1 Forecast
108.73

Abbott reported $3.09B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Agilent USD 466M 5M Jun/2025
AtriCure USD 19.86M 2.06M Dec/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Danaher USD 2.13B 252M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Hologic USD 330.4M 16.6M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
Solventum Corp USD 475M 176M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 69.99B 3.22B Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025